Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Effect of stopping inhaled therapies on mucus clearance while on elexacaftor/tezacaftor/ivacaftor

Effect of stopping inhaled therapies on mucus clearance while on elexacaftor/tezacaftor/ivacaftor

Resource Type

CF Research News

Authors

Scott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, Beth L Laube, Peter Mogayzel, Agathe Ceppe, Jihong Wu, Kirby Zeman, Steven M Rowe, David P Nichols, Alex H Gifford, William D Bennett, Nicole Mayer-Hamblett; SIMPLIFY MCC Study teams

References

J Cyst Fibros. 2024 Feb 13:S1569-1993(24)00018-3. doi: 10.1016/j.jcf.2024.02.003

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

Clinical trial [3]
Dornase alfa [4]
Hypertonic saline [5]
Mucociliary clearance [6]
Withdrawal [7]

Date

Tuesday, February 13, 2024

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/effect-stopping-inhaled-therapies-mucus-clearance-while

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-23-00207R3_FINAL_Donaldson_300324.pdf [2] https://pubmed.ncbi.nlm.nih.gov/38355350/ [3] https://www.ecfs.eu/research-article-keywords/clinical-trial [4] https://www.ecfs.eu/research-article-keywords/dornase-alfa [5] https://www.ecfs.eu/research-article-keywords/hypertonic-saline [6] https://www.ecfs.eu/research-article-keywords/mucociliary-clearance [7] https://www.ecfs.eu/research-article-keywords/withdrawal [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines